Ever Source Wealth Advisors, LLC Acumen Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 415 shares of ABOS stock, worth $738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
415
Previous 486
14.61%
Holding current value
$738
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ABOS
# of Institutions
72Shares Held
38.8MCall Options Held
31.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA14.9MShares$26.6 Million0.38% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$6.08 Million1.28% of portfolio
-
Franklin Resources Inc San Mateo, CA3.08MShares$5.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.84 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.95MShares$3.47 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $72.1M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...